COLL vs FAST
Collegium Pharmaceutical Inc (COLL) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the COLL and FAST stock pages for the full models.
Not investment advice.